Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
fibrosis10255 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A43906 | 30488626 | Aliment Pharmacol Ther | Editorial: stepwise risk stratification for both F3 and F4 fibrosis stage in NAFLD patients. | 2018 | Details |
| A43911 | 30481884 | Zhonghua Gan Zang Bing Za Zhi | [Transfection of angiotensin-converting-enzyme 2 gene inhibits hepatic fibrosis in rats with nonalcoholic fatty liver disease]. | 2018 | Details |
| A43922 | 30449686 | Cell Metab | Hepatocyte-Macrophage Acetoacetate Shuttle Protects against Tissue Fibrosis. | 2018 | Details |
| A43925 | 30444274 | J Ultrasound Med | Review of Liver Elastography Guidelines. | 2018 | Details |
| A43953 | 30362994 | Eur J Gastroenterol Hepatol | Overlooked muscle cramps in patients with chronic liver disease: in relation to the prevalence of muscle cramps. | 2019 | Details |
| A43956 | 30333544 | Am J Gastroenterol | Wine Consumption and Lower Risk of Advanced Liver Fibrosis: A True Effect or Unmeasured Confounding? A Longitudinal Analysis (ANRS CO13 HEPAVIH Cohort). | 2018 | Details |
| A44006 | 30156322 | Aliment Pharmacol Ther | Letter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey. | 2018 | Details |
| A44008 | 30156318 | Aliment Pharmacol Ther | Letter: significant burden of nonalcoholic fatty liver disease with advanced fibrosis in the USA: a cross-sectional analysis of 2011-2014 National Health and Nutrition Examination Survey - author's reply. | 2018 | Details |
| A44013 | 30152857 | Hepatology | Ultrasound Techniques for the Assessment of Liver Stiffness: A Correct Terminology. | 2019 | Details |
| A44031 | 30094401 | Hepatol Commun | A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care. | 2018 | Details |
| A44032 | 30080294 | Phytother Res | Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases. | 2018 | Details |
| A44035 | 30077626 | Gastroenterology | Managing Patients With Nonalcoholic Fatty Liver Disease: Is It Really Only About Fibrosis? | 2018 | Details |
| A44038 | 30070383 | Hepatology | Ductular Reaction in Liver Diseases: Pathological Mechanisms and Translational Significances. | 2018 | Details |
| A44040 | 30065476 | J Med Ultrasound | Ultrasound Evaluation of Liver Fibrosis. | 2017 | Details |
| A44048 | 30043282 | Dig Dis Sci | Correction to: Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration. | 2018 | Details |
| A44053 | 30027138 | Hepatol Commun | Patatin-like phospholipase domain containing 3 variants differentially impact metabolic traits in individuals at high risk for cardiovascular events. | 2018 | Details |
| A44057 | 30017528 | Int J Cardiol | Improved management of patients after acute coronary syndrome: using nonalcoholic fatty liver disease fibrosis score and ezetimibe? | 2018 | Details |
| A44064 | 29995306 | Eur J Clin Invest | Adipokine dysregulation and adipose tissue inflammation in human obesity. | 2018 | Details |
| A44066 | 29983203 | J Hepatol | Reply to: "NASH-related and cryptogenic cirrhosis similarities extend beyond cirrhosis": Cryptogenic cirrhosis should not be equated with NASH cirrhosis based on UNOS data mining and Bayesian 'doctrine of chances'. | 2018 | Details |
| A44074 | 29944727 | PLoS One | Correction: Prospective comparison among transient elastography, supersonic shear imaging, and ARFI imaging for predicting fibrosis in nonalcoholic fatty liver disease. | 2018 | Details |
| A44082 | 29881611 | United European Gastroenterol J | Risk factors associated with liver steatosis and fibrosis in chronic hepatitis B patient with component of metabolic syndrome. | 2018 | Details |
| A44084 | 29875591 | Ci Ji Yi Xue Za Zhi | Vegetarian diet, food substitution, and nonalcoholic fatty liver. | 2022 | Details |
| A44087 | 29851129 | Clin Exp Pharmacol Physiol | Chronic moderate alcohol consumption relieves high-fat high-cholesterol diet-induced liver fibrosis in a rat model. | 2018 | Details |
| A44090 | 29789277 | JMIR Res Protoc | Applicability of a Web-Based, Individualized Exercise Intervention in Patients With Liver Disease, Cystic Fibrosis, Esophageal Cancer, and Psychiatric Disorders: Process Evaluation of 4 Ongoing Clinical Trials. | 2018 | Details |
| A44091 | 29785143 | J Exp Pharmacol | Pilot study of the antifibrotic effects of the multikinase inhibitor pacritinib in a mouse model of liver fibrosis. | 2018 | Details |
| A44101 | 29747160 | Neoplasia | Targeting Liver Cancer and Associated Pathologies in Mice with a Mitochondrial VDAC1-Based Peptide. | 2018 | Details |
| A44117 | 29699861 | Dig Liver Dis | Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society. | 2018 | Details |
| A44135 | 29619423 | Hepatol Commun | A single blood test adjusted for different liver fibrosis targets improves fibrosis staging and especially cirrhosis diagnosis. | 2018 | Details |
| A44148 | 29578867 | Eur J Gastroenterol Hepatol | The relationship between urinary genistein levels and serum alanine aminotransferase levels in adults in the USA: National Health and Nutrition Examination Survey 1999-2010. | 2018 | Details |
| A44153 | 29568207 | World J Gastroenterol | Fatty liver in hepatitis C patients post-sustained virological response with direct-acting antivirals. | 2018 | Details |
| A44158 | 29549356 | Am J Gastroenterol | The management of incidental fatty liver found on imaging. What do we need to do? | 2018 | Details |
| A44160 | 29546739 | Panminerva Med | Non-invasive assessment of liver fibrosis: exploring the opportunity for a low-cost approach using the Genoa Line Quantification. | 2018 | Details |
| A44166 | 29534302 | Hepatology | Nonalcoholic fatty liver disease with cirrhosis increases familial risk for advanced fibrosis. | 2018 | Details |
| A44170 | 29523556 | Circ Cardiovasc Imaging | Prevalent Cardiovascular Disease Events and T1 Mapping Defined Hepatic Fibrosis. | 2018 | Details |
| A44176 | 29507905 | Hepatol Commun | Pyrroloquinoline quinone prevents developmental programming of microbial dysbiosis and macrophage polarization to attenuate liver fibrosis in offspring of obese mice. | 2018 | Details |
| A44187 | 29470938 | Radiology | Diagnostic Performance of MR Elastography for Liver Fibrosis in Children and Young Adults with a Spectrum of Liver Diseases. | 2018 | Details |
| A44207 | 29404453 | Hepatol Commun | Treating fatty liver disease by modulating mitochondrial pyruvate metabolism. | 2017 | Details |
| A44209 | 29404431 | Hepatol Commun | microRNA-200a: A stage-dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients. | 2017 | Details |
| A44210 | 29377437 | Liver Int | Steatosis affects the sensitivity but not the specificity of non-invasive fibrosis tests in non-alcoholic fatty liver disease - implications for screening strategies. | 2018 | Details |
| A44211 | 29376040 | Can J Gastroenterol Hepatol | Comment on "Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp". | 2017 | Details |
| A44217 | 29364097 | Acta Gastroenterol Belg | Contribution of PNPLA3 gene to the natural history of liver diseases. | 2018 | Details |
| A44223 | 29353249 | Gut | Plasma cell-free DNA methylation: a liquid biomarker of hepatic fibrosis. | 2018 | Details |
| A44227 | 29318378 | J Gastroenterol | Mac-2 binding protein glycan isomer (M2BPGi) is a new serum biomarker for assessing liver fibrosis: more than a biomarker of liver fibrosis. | 2018 | Details |
| A44240 | 29264552 | J Endocr Soc | Congenital Generalized Lipodystrophy Type 2 in a Patient From a High-Prevalence Area. | 2017 | Details |
| A44246 | 29254277 | Oncotarget | Apoptosis in the aging liver. | 2017 | Details |
| A44250 | 29247726 | J Hepatol | Cryptogenic vs. NASH-cirrhosis: The rose exists well before its name.... | 2017 | Details |
| A44259 | 29211940 | Hepatology | Liver fibrosis scores in the general population: Better risk indices are needed! | 2018 | Details |
| A44265 | 29201774 | Euroasian J Hepatogastroenterol | Hepatitis Action Plan and Changing Trend of Liver Disease in Japan: Viral Hepatitis and Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A44266 | 29199148 | Clin Gastroenterol Hepatol | Do Zones of Hepatic Steatosis Associate With Subtypes and Progression of Nonalcoholic Fatty Liver Disease in Children? | 2017 | Details |
| A44276 | 29175112 | Pharmacol Res | Chalcones as putative hepatoprotective agents: Preclinical evidence and molecular mechanisms. | 2017 | Details |
| A44277 | 29170098 | Clin Gastroenterol Hepatol | Serum Activity of Macrophage-Derived Adenosine Deaminase 2 Is Associated With Liver Fibrosis in Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A44299 | 29101980 | J Am Coll Radiol | ACR Appropriateness Criteria® Chronic Liver Disease. | 2017 | Details |
| A44301 | 29101348 | Sci Rep | Plasma amino acid profile associated with fatty liver disease and co-occurrence of metabolic risk factors. | 2017 | Details |
| A44304 | 29091323 | J Viral Hepat | Lower levels of dehydroepiandrosterone sulfate are associated with more advanced liver fibrosis in chronic hepatitis C. | 2017 | Details |
| A44321 | 29023886 | Aliment Pharmacol Ther | Editorial: optimising non-invasive screening for advanced liver fibrosis in NAFLD. | 2017 | Details |
| A44327 | 28994314 | Expert Rev Gastroenterol Hepatol | Preventing liver fibrosis in patients with NAFLD and the road ahead. | 2017 | Details |
| A44332 | 28966125 | J Hepatol | Back to Byzance: Querelles byzantines over NASH and fibrosis. | 2017 | Details |
| A44350 | 28874039 | Gut Liver | Hepatic and Splenic Volumetry Could Be Used as an Imaging Parameter to Evaluate Fibrosis Grades of the Diffuse Liver Disease Including Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A44382 | 28752925 | Liver Transpl | Management of portal hypertension before and after liver transplantation. | 2018 | Details |
| A44387 | 28741294 | Hepatology | Magnetic resonance elastography assessment of fibrosis in children with NAFLD: Promising but not perfect. | 2017 | Details |
| A44391 | 28727167 | Hepatology | Rediscussion on linearity between fibrosis stages and mortality risk in nonalcoholic fatty liver disease patients. | 2017 | Details |
| A44392 | 28727154 | Hepatology | Comments on "Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta-analysis". | 2017 | Details |
| A44408 | 28692538 | AIDS | Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients. | 2017 | Details |
| A44422 | 28676712 | Nat Rev Gastroenterol Hepatol | NAFLD: Increased familial risk of fibrosis in NAFLD. | 2017 | Details |
| A44423 | 28671424 | Am Fam Physician | Nonalcoholic Fatty Liver Disease: Identifying Patients at Risk of Inflammation or Fibrosis. | 2017 | Details |
| A44431 | 30992977 | Clin Liver Dis (Hoboken) | Putting it all together: Noninvasive diagnosis of fibrosis in nonalcoholic fatty liver disease in adults and children. | 2017 | Details |
| A44444 | 28618839 | Crit Rev Biochem Mol Biol | Sphingosine kinase and sphingosine-1-phosphate in liver pathobiology. | 2017 | Details |
| A44452 | 28590260 | Curr Opin Clin Nutr Metab Care | Ghrelin and autophagy. | 2017 | Details |
| A44461 | 28549675 | Clin Gastroenterol Hepatol | Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis. | 2017 | Details |
| A44471 | 28514295 | Medicine (Baltimore) | Cell death biomarker M65 is a useful indicator of liver inflammation and fibrosis in chronic hepatitis B: A cross-sectional study of diagnostic accuracy. | 2017 | Details |
| A44472 | 28513633 | Nat Rev Gastroenterol Hepatol | NAFLD: A gut microbiome signature for advanced fibrosis diagnosis in NAFLD. | 2017 | Details |
| A44503 | 33379824 | J Appl Lab Med | The Enhanced Liver Fibrosis (ELF) Panel: Analyte Stability Under Common Sample Storage Conditions Used in Clinical Practice. | 2017 | Details |
| A44510 | 28433112 | Handb Clin Neurol | Wilson disease - liver pathology. | 2017 | Details |
| A44512 | 28408383 | Gut | Pioglitazone for the treatment of NASH in patients with prediabetes or type 2 diabetes mellitus. | 2017 | Details |
| A44513 | 28404144 | Lancet Gastroenterol Hepatol | The fibrosis benefit index for assessment of therapeutic benefit in non-alcoholic steatohepatitis. | 2017 | Details |
| A44519 | 28381858 | Am J Gastroenterol | Low Utility of Noninvasive Fibrosis Scores in Young Adults with Nonalcoholic Fatty Liver Disease. | 2017 | Details |
| A44522 | 28370257 | Hepatology | Assessment of biopsy-proven liver fibrosis by two-dimensional shear wave elastography: An individual patient data-based meta-analysis. | 2017 | Details |
| A44526 | 28359541 | Atherosclerosis | Ischaemic stroke and liver fibrosis. | 2017 | Details |
| A44542 | 28293634 | Biomed Res Int | SECs (Sinusoidal Endothelial Cells), Liver Microenvironment, and Fibrosis. | 2017 | Details |
| A44545 | 28286195 | Clin Gastroenterol Hepatol | Diagnostic Accuracy of Noninvasive Fibrosis Scores in a Population of Individuals With a Low Prevalence of Fibrosis. | 2017 | Details |
| A44557 | 28218832 | Anal Chem | Noninvasive Strategy Based on Real-Time in Vivo Cataluminescence Monitoring for Clinical Breath Analysis. | 2017 | Details |
| A44565 | 28187500 | Anat Rec (Hoboken) | Basement Membrane Type IV Collagen and Laminin: An Overview of Their Biology and Value as Fibrosis Biomarkers of Liver Disease. | 2017 | Details |
| A44580 | 28105255 | World J Hepatol | PI3K/SHIP2/PTEN pathway in cell polarity and hepatitis C virus pathogenesis. | 2017 | Details |
| A44581 | 28103641 | Hepatology | Do we need controlled attenuation parameter adjustment for fibrosis estimation in nonalcoholic fatty liver disease patients? | 2017 | Details |
| A44599 | 28043092 | Aliment Pharmacol Ther | Letter: comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for noninvasive diagnosis of advanced fibrosis in biopsy-proven NAFLD. | 2017 | Details |
| A44600 | 28043090 | Aliment Pharmacol Ther | Letter: comparative diagnostic accuracy of magnetic resonance elastography vs. eight clinical prediction rules for non-invasive diagnosis of advanced fibrosis in biopsy-proven NAFLD - author's reply. | 2017 | Details |
| A44602 | 28027591 | Hepatology | TM6SF2 rs58542926 impacts lipid processing in liver and small intestine. | 2017 | Details |
| A44610 | 27986173 | Semin Ultrasound CT MR | Liver Function Assessment by Magnetic Resonance Imaging. | 2016 | Details |
| A44611 | 27981609 | Hepatology | The E3 ligase tripartite motif 8 targets TAK1 to promote insulin resistance and steatohepatitis. | 2017 | Details |
| A44615 | 27942586 | JCI Insight | IRF5 governs liver macrophage activation that promotes hepatic fibrosis in mice and humans. | 2016 | Details |
| A44619 | 27924102 | Am J Gastroenterol | The Heart Age Is Increased in Patients With Nonalcoholic Fatty Liver Disease and Correlates With Fibrosis and Hepatocyte Ballooning. | 2016 | Details |
| A44623 | 27918207 | Can J Physiol Pharmacol | Gemigliptin ameliorates Western-diet-induced metabolic syndrome in mice. | 2016 | Details |
| A44629 | 27880988 | Hepatology | Pioglitazone for advanced fibrosis in nonalcoholic steatohepatitis: New evidence, new challenges. | 2017 | Details |
| A44631 | 27862126 | Hepatology | The increasing burden of NAFLD fibrosis in the general population: Time to bridge the gap between hepatologists and primary care. | 2017 | Details |
| A44645 | 27823767 | J Pediatr | Reversal of Nonalcoholic Steatohepatitis in Adolescents after Metabolic Surgery. | 2016 | Details |
| A44651 | 27516341 | Nat Rev Endocrinol | Endoplasmic reticulum proteostasis in hepatic steatosis. | 2016 | Details |
| A44678 | 27435327 | Dig Dis Sci | Targeting Hepatic Fibrosis in Autoimmune Hepatitis. | 2016 | Details |
| A44679 | 27155555 | Clin Gastroenterol Hepatol | Association Between Severity of Obstructive Sleep Apnea and Blood Markers of Liver Injury. | 2016 | Details |
| A44690 | 27732084 | Endocrinology | RABL2 Is Required for Hepatic Fatty Acid Homeostasis and Its Dysfunction Leads to Steatosis and a Diabetes-Like State. | 2016 | Details |
| A44691 | 27729311 | BMJ | Ruling out fibrosis in non-alcoholic fatty liver disease. | 2016 | Details |